Prasad SM, Huang WC, Shore ND, Hu B, et al. Treatment of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102 +/- Transurethral Resection of Bladder Tumor (TURBT) Compared to TURBT Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS). J Urol 2023 Aug 7:101097JU0000000000003645. doi: 10.1097/JU.0000000000003645.
PMID: 37548555